This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Soligenix advances rare disease treatment with HyBryte therapy, targeting cutaneous T-cell lymphoma through innovative photodynamic approach. Breakthrough potential for 30 million Americans with rare diseases. #RareDiseases #MedicalInnovation
2025-12-03T18:20:11.933Z